Literature DB >> 16942825

Short QT syndrome: a case report and review of literature.

Li Xiong Lu1, Wei Zhou, Xingyu Zhang, Qin Cao, Kanglong Yu, Changqing Zhu.   

Abstract

The short QT syndrome has been recently recognised as a genetic ion channel dysfunction. This new clinical entity is associated with an incidence of sudden cardiac death, syncope, and atrial fibrillation in otherwise healthy individuals. The distinctive ECG pattern consists of an abnormally short QT interval, a short or even absent ST segment and narrow T waves. A 30-year-old resuscitated woman with short QT syndrome is described together with an example of the classic ECG characteristics. A short-coupled variant of torsade de pointes was reveal on Holter recordings. The implantable cardioveter defibrillator seems to be the therapy of choice to prevent from sudden cardiac death. Quinidine proved to be efficient in prolonging the QT interval and rendering ventricular tachyarrhythmias non-inducible in patients with a mutation in KCNH2 (HERG). Our preliminary data suggest amiodarone combined with beta-blocker may be helpful in treating episodes of polymorphic ventricular tachycardia for patients with an unknown genotype. Because the short QT syndrome often involves young patients with an apparently normal heart, it is imperative for physicians to recognize the clinical features of the short QT syndrome in making a timely correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16942825     DOI: 10.1016/j.resuscitation.2006.03.011

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  8 in total

1.  Short QT Syndrome - Review of Diagnosis and Treatment.

Authors:  Boris Rudic; Rainer Schimpf; Martin Borggrefe
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30

Review 2.  Short QT syndrome review.

Authors:  Nathan E Van Houzen; Alawi A Alsheikh-Ali; Ann C Garlitski; Munther K Homoud; Jonathan Weinstock; Mark S Link; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2008-02-26       Impact factor: 1.900

3.  Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.

Authors:  M J McPate; R S Duncan; J C Hancox; H J Witchel
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

Review 4.  Short QT syndrome: from bench to bedside.

Authors:  Chinmay Patel; Gan-Xin Yan; Charles Antzelevitch
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-08

5.  Congenital short QT syndrome.

Authors:  Lia Crotti; Erika Taravelli; Giulia Girardengo; Peter J Schwartz
Journal:  Indian Pacing Electrophysiol J       Date:  2010-02-01

6.  Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome.

Authors:  Chinmay Patel; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2008-01-29       Impact factor: 6.343

Review 7.  Pharmacological approach to the treatment of long and short QT syndromes.

Authors:  Chinmay Patel; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2008-04       Impact factor: 12.310

8.  Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.

Authors:  Cunjin Luo; Kuanquan Wang; Henggui Zhang
Journal:  Biomed Eng Online       Date:  2017-06-07       Impact factor: 2.819

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.